Cardio Diagnostics Holdings, Inc. (CDIOW)
US — Healthcare Sector
Automate Your Wheel Strategy on CDIOW
With Tiblio's Option Bot, you can configure your own wheel strategy including CDIOW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CDIOW
- Rev/Share 0.0118
- Book/Share 6.7474
- PB 0.5884
- Debt/Equity 0.0532
- CurrentRatio 19.4879
- ROIC -0.4873
- MktCap 6902679.0
- FreeCF/Share -3.1977
- PFCF -1.2802
- PE -1.1433
- Debt/Assets 0.0493
- DivYield 0
- ROE -0.8456
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
No ratings available. |
News
About Cardio Diagnostics Holdings, Inc. (CDIOW)
- IPO Date
- Website https://cardiodiagnosticsinc.com
- Industry Biotechnology
- CEO Meeshanthini V. Dogan
- Employees 13
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.